Pacira BioSciences (PCRX) Intangibles (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Intangibles of $353.2 million for Q1 2026, down 18.79% year-over-year from $435.0 million in Q1 2025, and down 4.04% quarter-over-quarter from $368.1 million in Q4 2025.
Pacira BioSciences (PCRX) Intangibles (2010 - 2026) Analysis & Trends
Pacira BioSciences' Intangibles history runs 14 years deep, the most recent figure standing at $353.2 million for Q1 2026.
- In Q1 2026, Intangibles fell 18.79% year-over-year to $353.2 million; the TTM figure through Mar 2026 stood at $353.2 million (down 18.79% YoY), while the FY2025 annual figure was $368.1 million, down 13.59% from the prior year.
- Intangibles for Q1 2026 stood at $353.2 million, down from $368.1 million in the prior quarter.
- The five-year high for Intangibles was $609.6 million in Q1 2022, with the low at $353.2 million in Q1 2026.
- The 5-year median for Intangibles is $468.9 million (2024), against an average of $476.3 million.
- The sharpest annual moves came in 2022 and 2026: Intangibles soared 544.76% in 2022, then fell 18.79% in 2026.
- Pacira BioSciences' Intangibles stood at $540.5 million in 2022, then decreased by 10.6% to $483.3 million in 2023, then dropped by 11.85% to $426.0 million in 2024, then slipped by 13.59% to $368.1 million in 2025, then dropped by 4.04% to $353.2 million in 2026.
- Business Quant data shows PCRX's Intangibles at $353.2 million in Q1 2026, $368.1 million in Q4 2025, and $382.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.12 Bn |
| 10 | Pacira BioSciences | 945.31 Mn | 694.28 Mn | 148.24 Mn | 285.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 285.48 Mn |
| Mar 31, 2026 | 353.23 Mn |
| Dec 31, 2025 | 368.10 Mn |
| Sep 30, 2025 | 382.40 Mn |
| Jun 30, 2025 | 422.56 Mn |
| Mar 31, 2025 | 434.97 Mn |
| Dec 31, 2024 | 425.97 Mn |
| Sep 30, 2024 | 440.29 Mn |
| Jun 30, 2024 | 454.61 Mn |
| Mar 31, 2024 | 468.94 Mn |
| Dec 31, 2023 | 483.26 Mn |
| Sep 30, 2023 | 497.58 Mn |
| Jun 30, 2023 | 511.90 Mn |
| Mar 31, 2023 | 526.22 Mn |
| Dec 31, 2022 | 540.55 Mn |
| Sep 30, 2022 | 581.00 Mn |
| Jun 30, 2022 | 595.32 Mn |
| Mar 31, 2022 | 609.65 Mn |
| Dec 31, 2021 | 623.97 Mn |
| Sep 30, 2021 | 90.62 Mn |